Predictors of sustained virologic response (age, HCV RNA concentration, liver fibrosis, <i>IL28B</i> rs12979860 CC and rs8099917 TT genotype, and <i>IFN-L4</i> ss469415590 TT/TT genotype) in genotype 1, 2, and 3 infected patients.

<p>GT1 (d) – HCV genotype 1 infected patients receiving dual-therapy (PEG-INF + Ribavirin); GT1 (t) – HCV genotype 1 infected patients receiving triple-therapy (TPR + PEG-INF + Ribavirin).</p><p>GT – genotype; BL – baseline; n.a. – not applicable.</p>1<p>p-values from Wilcoxon-Mann-Whitney-U-test, Kruskal-Wallis-test and χ2 test for quantitative and categorical predictors, respectively.</p><p>Predictors of sustained virologic response (age, HCV RNA concentration, liver fibrosis, <i>IL28B</i> rs12979860 CC and rs8099917 TT genotype, and <i>IFN-L4</i> ss469415590 TT/TT genotype) in genotype 1, 2, and 3 infected patients.